[go: up one dir, main page]

GT200700100A - (S) -N-METHYLNATREXONE - Google Patents

(S) -N-METHYLNATREXONE

Info

Publication number
GT200700100A
GT200700100A GT200700100A GT200700100A GT200700100A GT 200700100 A GT200700100 A GT 200700100A GT 200700100 A GT200700100 A GT 200700100A GT 200700100 A GT200700100 A GT 200700100A GT 200700100 A GT200700100 A GT 200700100A
Authority
GT
Guatemala
Prior art keywords
mntx
methylnatrexone
treat
methods
prepare
Prior art date
Application number
GT200700100A
Other languages
Spanish (es)
Inventor
Wagoner Howard
Sanghvi Suketu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GT200700100A priority Critical patent/GT200700100A/en
Publication of GT200700100A publication Critical patent/GT200700100A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA (S)-N-METILNATREXONA (S-MNTX), METODOS SINTETICOS ESTEREOSELECTIVOS PARA PREPARAR LA S-MNTX, PREPARACIONES FARMACEUTICAS QUE CONTIENEN DICHA S-MNTX ASI COMO METODOS DE SU USO, COMO POR EJEMPLO, PARA TRATAR SINDROME DEL COLON IRRITABLE, O BIEN PARA TRATAR O PREVENIR EL DOLOR. T2007THE PRESENT INVENTION REFERS TO THE (S) -N-METHYLNATREXONE (S-MNTX), STEREOSELECTIVE SYNTHETIC METHODS TO PREPARE THE S-MNTX, PHARMACEUTICAL PREPARATIONS CONTAINING S-MNTX AS WELL AS METHODS OF USE, AS FOR EXAMPLE, AS FOR EXAMPLE TREAT IRRITABLE COLON SYNDROME, OR TO TREAT OR PREVENT PAIN. T2007

GT200700100A 2007-11-13 2007-11-13 (S) -N-METHYLNATREXONE GT200700100A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GT200700100A GT200700100A (en) 2007-11-13 2007-11-13 (S) -N-METHYLNATREXONE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GT200700100A GT200700100A (en) 2007-11-13 2007-11-13 (S) -N-METHYLNATREXONE

Publications (1)

Publication Number Publication Date
GT200700100A true GT200700100A (en) 2010-02-11

Family

ID=47044098

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200700100A GT200700100A (en) 2007-11-13 2007-11-13 (S) -N-METHYLNATREXONE

Country Status (1)

Country Link
GT (1) GT200700100A (en)

Similar Documents

Publication Publication Date Title
CO6321189A2 (en) BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
CL2007001869A1 (en) COMPOUNDS DERIVED FROM BENCIMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITIONS; AND USE FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES MODULATED WITH FXR AGONISTS, SUCH AS DISLIPIDEMIAS, DIABETES, CANCER, OSTEOPOROSIS AND E
GT200900230A (en) 4-ARIL-1,4-DIHIDRO-1,6-NAFTIRIDINAMIDES REPLACED AND USE
CR11731A (en) COMPOSITIONS AND PROCEDURES FOR PREPARATION AND USE
NI201000055A (en) 2 '- FLUORO - 2' - DEOXYTETHYDROURIDINES AS INHIBITORS OF CITIDINE DESAMINE.
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
EA201001329A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
NI201000044A (en) BUPROPION BROMHYDRATE AND THERAPEUTIC APPLICATIONS
BRPI0808775A2 (en) compounds and compositions as modulators of gpr119 activity
ECSP13011139A (en) ANTIBODIES AGAINST 2 HUMAN ANGIOPOYETINE
CL2011000835A1 (en) Compounds derived from spiro-oxindole; sodium channel modulators; pharmaceutical composition comprising said compound; and use in the treatment of pain, depression, cardiovascular, respiratory, psychiatric diseases, among others.
CL2008003593A1 (en) Isoxazolo-pyridazine derived compounds; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cognitive disorders such as Alzheimer's
CR10149A (en) CYTOTOXIC AGENTS UNDERSTANDING NEW TOMAIMYCIN DERIVATIVES AND THERAPEUTIC USE
EA201001332A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
ECSP11011390A (en) ESPIRO-AMIDAS SUBSTITUTED COMPOUNDS
CL2008002076A1 (en) Compounds derived from substituted aryloxazoles; process for preparing said compounds; pharmaceutical composition comprising them; and its use to treat diabetes, metabolic syndrome, dyslipidemias, among other diseases.
CL2010001538A1 (en) Compounds derived from substituted pyrazolo-quinazoline, modulators of the activity of protein kinases; pharmaceutical composition; and its use for the treatment of cancer, or a cell proliferative disorder.
ECSP13012573A (en) 6-amino-nicotinamides substituted as modulators of KCNQ2 / 3
CL2007002971A1 (en) COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS.
PA8784101A1 (en) OXAZOLIDINONES REPLACED AND ITS USE
UY30572A1 (en) N- (1-FTALAZIN-1-IL-PIPERIDIN-4-IL) -AMIDAS AS MODULATORS OF THE EP2 RECEIVER
EA201001330A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
CL2009000309A1 (en) Aromatic fluoroglycoside derivatives, pharmaceutical composition containing these compounds, procedure to prepare it and its use in the treatment of type 1 and type 2 diabetes.
CR11259A (en) BUPROPION BROMHYDRATE AND THERAPEUTIC APPLICATIONS